Related by context. All words. (Click for frequent words.) 76 humanized antibody 76 human monoclonal antibody 75 investigational humanized monoclonal antibody 74 proteasome inhibitor 73 orally bioavailable 72 humanized anti 72 potent inhibitor 72 IgG1 antibody 72 selective inhibitor 72 antibody MAb 72 polymerase inhibitor 72 targeting CD# 72 sodium glucose cotransporter 72 multi kinase inhibitor 71 IAP inhibitor 71 liposomal formulation 70 targeted radiotherapeutic 70 antisense drug 70 chemokine receptor 70 histone deacetylase HDAC inhibitor 70 receptor tyrosine kinase inhibitor 70 chimeric monoclonal antibody 70 monoclonal antibody 70 CD# monoclonal antibody 70 MEK inhibitor 70 angiogenesis inhibitor 69 immunomodulator 69 JAK inhibitor 69 targeted antifolate 69 selective agonist 69 selective antagonist 69 huC# DM4 69 pan HDAC inhibitor 69 small molecule inhibitor 69 kinase inhibitor 69 oral prodrug 69 prodrug 69 humanized monoclonal antibodies 69 Ofatumumab 69 MT# MEDI 69 antibody fragment 69 Daclizumab 69 tyrosine kinase inhibitor 69 VEGF receptor 69 AEG# 69 Factor VIIa 69 HCV protease inhibitor 69 ADP receptor antagonist 69 RhuDex ® 69 humanized monoclonal 69 PKC# 69 Epratuzumab 69 nucleoside analog 69 alpha folate receptor 69 JAK1 69 injectable formulation 69 M2 subunit 68 HSP# inhibitor 68 IgG1 monoclonal antibody 68 Aurora kinase 68 mertansine 68 MTP inhibitor 68 PEGylated Fab fragment 68 small molecule glucokinase 68 Panzem R 68 ErbB3 68 drug conjugate 68 ketolide antibiotic 68 CYC# 68 somatostatin analogue 68 chemically modified siRNA 68 peripherally acting 68 TLR9 agonist 68 PDE4 inhibitor 68 Vicinium TM 68 IMA# 68 protein kinase inhibitor 68 CD# molecule 68 vascular disrupting agent 68 investigational oral inhibitor 68 mitogen activated ERK kinase 68 sphingosine 1 68 novel topoisomerase 68 antisense oligonucleotide 68 selective kinase inhibitor 68 soluble tumor necrosis 68 dasatinib Sprycel ® 68 mu opioid receptor antagonist 68 erlotinib Tarceva ® 68 siRNA therapeutic 68 reslizumab 68 HCV protease 68 Belimumab 68 novel histone deacetylase 68 Nanobody 68 PARP inhibitor 68 orally administered inhibitor 68 Sym# 68 Pradefovir 68 JAK2 inhibitor 68 histone deacetylase HDAC 67 synthetic peptide 67 LymphoStat B belimumab 67 protein tyrosine phosphatase 1B 67 Angiolix R 67 investigational monoclonal antibody 67 Janus Kinase 67 vinca alkaloid 67 selectively inhibit 67 non nucleoside inhibitor 67 EGFr 67 highly selective inhibitor 67 Pathway Inhibitor 67 Bavituximab 67 nicotinic alpha 7 67 HuLuc# 67 Anticalin R 67 CCR9 antagonist 67 Tyrima 67 CCR2 67 immunotherapeutic agent 67 CCR5 antagonist 67 investigational drug 67 imatinib Gleevec ® 67 PI3K/Akt pathway inhibitor 67 KSP inhibitor 67 Nexavar ® 67 partial agonist 67 PNP inhibitor 67 2 methoxyestradiol 67 Enkephalin 67 Vandetanib 67 Proxinium TM 67 selective modulator 67 ATL# [001] 67 receptor agonist 67 epothilone 67 luteinizing hormone releasing 66 Factor VEGF 66 highly selective endothelin 66 Tofacitinib 66 Xanafide 66 novel peptide 66 small molecule inhibitors 66 BAY #-# 66 selective androgen receptor modulator 66 oral antiviral 66 CCX# 66 Talabostat 66 thymalfasin 66 CCR9 66 TNF Tumor Necrosis Factor 66 HQK 66 developing Bicifadine serotonin 66 volociximab 66 FLT3 66 epothilones 66 Traficet EN 66 5 HT6 66 IMiD 66 Fc fusion protein 66 signal transduction inhibitor 66 isoform selective 66 PEGylated 66 anti CD# antibody 66 Zolinza 66 small molecule Hedgehog 66 Luteinizing Hormone Releasing Hormone 66 mTOR inhibitor 66 investigational antibody 66 SGLT2 66 peptibody 66 anti EGFR antibody 66 Enzastaurin 66 Carfilzomib 66 CD# antibody [001] 66 ENMD # 66 IAP inhibitors 66 Dapagliflozin 66 therapeutic monoclonal antibody 66 HCV polymerase 66 irreversible inhibitor 66 novel orally administered 66 HDAC inhibitor 66 Omacetaxine mepesuccinate 66 selectively inhibits 66 diarrhea predominant irritable 66 NS#/#A protease 66 antibody MT# 66 Onconase 66 anti CD3 monoclonal 66 HuMax CD4 66 PRTX 66 systemic RNAi therapeutic 66 polymerase inhibitors 66 inhaled formulation 66 Pralatrexate 66 oncolytic 66 MT#/MEDI-# 66 MAb 66 MAGE A3 ASCI 66 NTDDS 66 Tumour Vascular Disrupting Agent 66 inhibitor PRO 66 proteasome inhibitors 66 Debio 66 Guanilib 66 MEK inhibitors 66 Olaparib 66 neuraminidase inhibitor 66 immune modulator 66 monoclonal antibody mAb 66 CDK inhibitor 66 Azedra 65 PEGylated anti 65 A3 adenosine receptor 65 depsipeptide 65 MKC# MT 65 receptor antagonist 65 Aflibercept 65 Elotuzumab 65 Sapacitabine 65 receptor antagonists 65 Sudhir Agrawal D.Phil 65 AAG geldanamycin analog 65 tyrosine kinase receptor 65 Elesclomol 65 opioid receptor antagonist 65 anticancer agent 65 TREANDA 65 Preclinical studies suggest 65 CTLA 4 65 Blinatumomab 65 YONDELIS 65 myelofibrosis polycythemia vera 65 sunitinib Sutent ® 65 vascular disrupting agents 65 monoclonal antibody MAb 65 ABL inhibitor 65 PI3 kinase 65 immunomodulating 65 immunostimulatory 65 investigational pan BCR 65 Janus kinase 65 Aviptadil 65 Tumor Necrosis Factor 65 Voreloxin 65 GV# [001] 65 Maribavir 65 HCD# [002] 65 Amrubicin 65 MET VEGFR2 65 FOLOTYN ® 65 Vaprisol 65 bispecific 65 Intravenous Human 65 hypoxia inducible factor 65 OncoVEX GM CSF 65 RNAi therapeutic targeting 65 long acting muscarinic 65 Archexin 65 poly ADP ribose polymerase 65 investigational compound 65 cyclin dependent kinase inhibitor 65 Bezielle 65 IMC #B 65 B lymphocyte stimulator 65 histone deacetylase inhibitor 65 fusion protein 65 ANG# 65 chemotherapeutic agent 65 Vidofludimus 65 IMiDs R 65 delta isoform 65 inhibitor RG# 65 DB# [003] 65 Aurora kinase inhibitor 65 sodium thiosulfate STS 65 Angiolix 65 cathepsin K inhibitor 65 cytotoxin 65 oxidative stress inducer 65 Hsp# inhibitor 65 humanised monoclonal antibody 65 PTH analogue 65 Transdrug ® nanoparticle 65 HCV NS3 protease 65 treat lupus renal 65 AKT inhibitor 65 immune modulators 65 CYT# potent vascular disrupting 65 Mipomersen 65 investigational compounds 65 TYZEKA 65 metaglidasen 65 accumulate preferentially 65 Hsp# inhibitors 65 small molecule modulators 65 VEGF receptors 65 T#I [002] 65 HyperAcute 65 mTOR mammalian target 65 mitotic kinesin 65 product Fentanyl TAIFUN 65 hypereosinophilic syndrome 65 XL# anticancer compounds 65 HER1 65 PRT# 65 HER2/neu 65 pertuzumab 65 dasatinib Sprycel 65 BCR ABL inhibitors 65 GW# [003] 65 IGF 1R 65 HGS ETR2 65 Phase #b/#a clinical 65 CEQ# 65 #HT#A 65 Bortezomib 64 NEUGENE 64 investigational immunotherapy 64 nucleotide analog 64 PDX pralatrexate 64 anti CD3 64 Gleevec resistant 64 MNTX 64 Epidermal Growth Factor Receptor 64 docetaxel Taxotere R 64 PI3K inhibitor 64 selectively binds 64 rNAPc2 64 modulator SERM 64 selective inhibition 64 Alfacell proprietary ribonuclease 64 Azixa 64 hormone LHRH antagonist 64 selective serotonin 2C receptor 64 HepDirect prodrug 64 BiTE 64 Nanobody ® 64 TRAIL R2 64 PTP 1B 64 Epothilones 64 BAL# [001] 64 peptidic compound 64 Fx #A 64 NXL# 64 Seliciclib 64 Linaclotide 64 antisense inhibitor 64 Tarvacin 64 Tarvacin TM 64 oral Factor Xa 64 XmAb# 64 SAR# [002] 64 obatoclax 64 MORAb 64 c Raf kinase 64 novel cardiac myosin 64 selective orally bioavailable 64 MKC# MKC# PP 64 monoclonal 64 bevacizumab Avastin ® 64 DNA intercalator 64 GPNMB 64 Multimeric 64 induces apoptosis 64 fusion inhibitors 64 Annamycin 64 Hsp# Inhibitor 64 Interferon alpha 64 ErbB1 64 selective adenosine 64 immunomodulatory 64 ALN TTR 64 recombinant adeno associated 64 histone deacetylase 64 cancer vaccine Norelin 64 induce apoptosis 64 systemically administered 64 VAPRISOL 64 potently inhibited 64 potent topoisomerase II 64 Thiarabine 64 CXCR4 64 Nimotuzumab 64 Interferon alfa 64 Bruton tyrosine kinase Btk 64 Sphingomab TM 64 cilengitide 64 Panzem R NCD 64 Methylnaltrexone 64 lipopeptide 64 HGS# 64 Omacetaxine 64 XL# XL# 64 anticancer compound 64 relapsed leukemia 64 apoptosis proteins 64 immunotherapeutic 64 PI3K/Akt pathway 64 OMP #R# 64 VEGFR2 64 SERMs 64 amino acid peptide 64 Liposomal 64 VEGFR2 inhibitor 64 Trabectedin 64 Abiraterone acetate 64 vidofludimus 64 anticancer agents 64 therapeutic monoclonal antibodies 64 human HuCAL antibody 64 AT1R 64 beta 1a 64 investigational oral 64 Phase Ib clinical trials 64 MMAE 64 cancer immunotherapies 64 5 HT2B receptor 64 UPLYSO 64 lexidronam injection 64 CD# antigen 64 Nanobodies 64 E2F 64 EGF receptor 64 polysaccharide polymer 64 tumor xenograft models 64 potent cytotoxic 64 THR beta agonist 64 tiapamil 64 HCV RNA polymerase 64 telomerase reverse transcriptase 64 Monoclonal antibody 64 alkylating agent 64 oral proteasome inhibitor 64 sorafenib tablets 64 otelixizumab 64 leukemia AML 64 Angiocept 64 docetaxel Taxotere ® 64 small molecule 64 factor Xa 64 JAK3 64 Aplidin 64 herpes simplex viruses 64 therapeutic antibody 64 Vascular Endothelial Growth 64 Squalamine 64 VitiGam 64 Genentech Rituxan 64 renin inhibitor 64 phosphate S1P 64 HDACi 64 fusion inhibitor 64 mGluR5 negative 64 OHR/AVR# 64 thrombopoietin 64 Personalized Immunotherapy 64 cutaneous T 64 thrombin receptor 64 potently inhibit 64 non nucleoside 64 Rituxan rituximab 64 huN# DM1 64 Anidulafungin 64 CD4 monoclonal antibody 64 MVA BN R 64 anti angiogenic agent 64 CD3 monoclonal antibody 64 recombinant subunit vaccine 64 potent antiproliferative 64 BRAF inhibitor 64 c MET 64 MUC1 64 intranasal formulation 63 inhibits protein synthesis 63 potential vanilloid 63 immunotoxin 63 mGluR2 positive 63 oncolytic virus therapies 63 Kinase Inhibitor 63 pathophysiological effects 63 transient receptor 63 Aplidin R 63 pharmacological chaperone 63 receptor partial agonist 63 nicotinic acetylcholine receptor 63 phase IIb clinical 63 ceftazidime 63 drug pipeline TAFA# 63 PDGF receptor 63 candidate deforolimus 63 essential thrombocythemia ET 63 prophylactic vaccine 63 small molecule tyrosine 63 BiTE antibody 63 HepaGam B 63 ProMune 63 relapsing multiple sclerosis 63 Zorbtive TM 63 Ridaforolimus 63 murine monoclonal antibody 63 PSN# [002] 63 ofatumumab HuMax CD# 63 Civacir 63 Pancreate 63 Ceftaroline 63 Pharmacokinetics PK 63 virus HCV protease inhibitor 63 vapreotide acetate 63 LHRH antagonists 63 #D#C# 63 anticancer therapeutics 63 chronic eosinophilic leukemia 63 trabectedin 63 Chemokine Receptor 63 patented Bioral 63 mAb 63 5 HT6 receptor 63 triggers apoptosis programmed 63 Tesetaxel 63 interferon IFN 63 C5aR 63 IRX 2 63 vWF 63 Anticalin 63 Ceflatonin R 63 TLR7 63 immune stimulatory 63 humanised antibody 63 compound PMX # 63 Ustekinumab 63 Triphendiol 63 radiation sensitizer 63 polyclonal antibody 63 NPC 1C 63 Dacetuzumab 63 HuMax EGFr 63 Curaxin CBLC# 63 Romiplostim 63 Perifosine 63 personalized cellular immunotherapy 63 Ganciclovir 63 angiotensin receptor blocker ARB 63 EGFR inhibitors 63 reversible inhibitors 63 oral isoform selective HDAC 63 dyskinesia PD LID 63 Tarceva TM 63 chemotherapy induced neutropenia 63 IMC A# 63 PI3K/mTOR 63 agonistic human 63 cytostatic 63 Clevudine 63 TRC# 63 Irinotecan 63 TTR gene 63 thalidomide Thalomid 63 potently inhibits 63 Sphingomab 63 Protein Kinase C 63 insulin sensitizers 63 Iluvien ® 63 EGFR HER2 63 monoclonal anti 63 Pazopanib 63 personalized immunotherapy 63 monoclonal antibody IgG1 Mab 63 nucleoside analogue 63 activin receptor type 63 Ceflatonin 63 Copegus ribavirin 63 secretory phospholipase A2 63 myeloproliferative diseases 63 relapsed multiple myeloma 63 formerly LymphoStat B 63 RGB # 63 uPA 63 anti secretory 63 clinically validated targets 63 topically applied SEPA 63 methionine aminopeptidase 63 cytoprotective 63 milatuzumab 63 HGS ETR1 mapatumumab 63 antibody 63 factor TNF receptor 63 cardio renal 63 PD LID 63 Cathepsin S 63 oral kinase inhibitor 63 Aurexis R 63 EndoTAG TM -1 63 TLR9 agonists 63 Aurexis 63 gefitinib Iressa 63 Imprime PGG 63 CCR1 63 Leukine ® 63 small molecule chemotherapeutic 63 delivered RNAi therapeutic 63 prostate cancer antigen prostatic 63 Tanespimycin 63 RANK Ligand inhibitor 63 drug zotarolimus 63 Dalbavancin 63 lysophosphatidic acid LPA 63 Radezolid 63 Interferon gamma 63 subcutaneously administered 63 LY# [003] 63 humanized antibodies 63 myeloproliferative disorders 63 reversible inhibitor 63 PEGylated interferon 63 L Annamycin 63 molecular imaging radiopharmaceutical 63 alpha interferon 63 GSK '# 63 ligand TRAIL 63 protein mTOR 63 elotuzumab 63 CD# receptor 63 intravenously administered 63 Ecallantide 63 IL #E 63 synthetic retinoid 63 AA amyloidosis 63 Temsirolimus 63 OMP #M# 63 delivers fluocinolone acetonide FA 63 Factor Receptor 63 generation antisense 63 coronary vasodilation 63 metastatic colorectal 63 EpCAM 63 ZACTIMA 63 cyclin dependent kinase CDK 63 solithromycin 63 NS5B polymerase 63 Zoraxel TM 63 developing TB4 63 panitumumab Vectibix 63 P#X# 63 Otelixizumab 63 Denufosol 63 cell lymphoma CTCL 63 immune modulatory 63 HepeX B TM 63 echinocandin 63 androgen receptor AR 63 IMiDs ® 63 AEGR 63 Onalta 63 GM CSF 63 TNF alpha selectively neutralizing 63 oral ghrelin agonist 63 acyclovir Lauriad R 63 hepatitis C HCV 63 recombinant fusion 63 iobenguane 62 orally administered 62 Tezampanel 62 fusion proteins 62 triciribine phosphate monohydrate 62 PEG SN# 62 hypoxia activated prodrug 62 trastuzumab Herceptin R 62 Tumor necrosis factor 62 Bafetinib 62 RAF kinase 62 TKM ApoB 62 Elvitegravir 62 cyclin dependent kinase 62 gemcitabine Gemzar 62 LY# [002] 62 Ixabepilone 62 vemurafenib 62 VA# [002] 62 non nucleoside HCV 62 ophthalmic indications 62 fostamatinib 62 oral dihydropyrimidine dehydrogenase DPD 62 INT# [002] 62 Lixivaptan 62 c myc 62 PLX# 62 EOquin 62 Virulizin R 62 HER pathway 62 XmAb ™ 62 human antibody therapeutics 62 TNF receptor 62 Prodarsan R 62 IMPDH inhibitor 62 receptor alpha 62 novel immunomodulatory 62 inhibitor 62 bioactive lipids 62 oral dual endothelin 62 Solazed ™ 62 Orally administered 62 HGS ETR1 62 SCH # 62 Cannabinor 62 FK# 62 IgG1 62 CB2 selective receptor agonist 62 enzyme inhibitor 62 TNFa 62 cetuximab Erbitux R 62 cannabinor 62 proprietary polysaccharide 62 cytotoxic 62 LHRH antagonist 62 pseudobulbar affect PBA 62 DOS# 62 class anticancer quinolone 62 Atiprimod 62 HER3 62 novel antibody therapeutics 62 VEGF inhibitors 62 Eculizumab 62 Aclidinium 62 biologic therapy 62 peptide CGRP 62 Symadex 62 IL 1ß 62 leukotriene pathway 62 tafamidis 62 peripherally restricted 62 evaluating tivozanib 62 orally dosed 62 Tarmogen 62 NS5b 62 familial amyloidotic polyneuropathy FAP 62 carbohydrate polymer 62 Anticalin ® 62 Yondelis ® 62 compound ITMN 62 novel orally bioavailable 62 Solazed TM 62 immunosuppressive compound 62 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 62 antisense inhibitors 62 relapsed refractory multiple myeloma 62 kidney urologic 62 E#F# 62 allosteric modulator NAM 62 receptor monoclonal antibody 62 CD#L 62 PSMA ADC 62 seliciclib CYC# 62 LymphoStat B TM 62 gamma secretase inhibitor 62 Serostim R 62 Onalta ™ 62 Hedgehog signaling pathway 62 Phase 2b clinical trials 62 immunotherapeutic vaccine 62 Resten NG 62 opioid induced bowel dysfunction 62 TG# [003] 62 Ocrelizumab 62 Icatibant 62 delta opioid receptor 62 pan histone deacetylase 62 XmAb 62 receptors EGFR 62 nucleoside reverse transcriptase inhibitor 62 TRX1 62 Boceprevir 62 anti TNF alpha 62 REP# 62 mda 7 62 ribonucleotide reductase clinically validated 62 fluoropyrimidine 62 polycythemia vera PV 62 HCV polymerase inhibitor 62 acadesine 62 5 HT2A receptor 62 oral Janus kinase 62 histone deacetylase HDAC inhibitors 62 Phase Ib clinical 62 MGd 62 Amplimexon 62 nucleoside analogues 62 Interferon beta 62 oncolytic virus 62 metastatic neuroendocrine tumors 62 selective immunoproteasome inhibitor 62 Deforolimus 62 novel prodrug 62 signal transduction inhibitors 62 AP# [003] 62 candidate Zenvia 62 acetylcholinesterase AChE 62 Curaxins 62 TNF receptors 62 valtorcitabine 62 CYP#A# CYP#D# 62 tumor antigen 62 JAK inhibitors 62 CRTH2 62 Unit Dose Budesonide 62 PARP inhibitors 62 cholesteryl ester transfer 62 Cyclooxygenase Inhibiting Nitric Oxide 62 glucagon receptor 62 novel VDA molecule 62 taxane derivative 62 Campath ® 62 hormone LHRH 62 methylnaltrexone bromide 62 alpha 2b 62 factor G CSF 62 acetonide FA 62 CA4P 62 HCV NS5B polymerase 62 subcutaneous formulation 62 bortezomib Velcade 62 Receptor Antagonist 62 mild vasodilator 62 survivin 62 agonist compounds 62 Alfimeprase 62 interleukin IL -# 62 vesicular monoamine transporter 62 Onco TCS 62 chemokine 62 PGL# 62 subtype selective 62 Syk kinase 62 OncoVEX 62 Anticalins R 62 lintuzumab SGN 62 cell malignancies 62 Trastuzumab 62 peptide antigens 62 Aptivus ® 62 NS4A 62 ganciclovir 62 anti CD# monoclonal 62 Besivance 62 Epothilone D 62 receptor subtype 62 tyrosine kinase 62 drug ISA# 62 angiotensin II receptor blocker 62 SGLT 62 antifungal agent 62 receptor blocker 62 TG# [001] 62 EZN 62 ganetespib 62 PI3K inhibitors 62 BAL# [002] 62 GRN#L 62 MKC# 62 lipoglycopeptide 62 PORxin TM 62 JAK#/JAK# 62 HIV integrase inhibitor 62 HCV protease inhibitors 62 5 HT2A serotonin 62 adenoviral 62 kinesin spindle protein 62 receptor CXCR4 62 small molecule activators 62 selective inverse agonist 62 Dasatinib 62 Actemra tocilizumab 62 BMS # 62 constitutively activated 62 Insegia 62 molecule epidermal 62 Virulizin ® 62 stable nucleic acid 62 SPL# Gel vaginal microbicide 62 broad spectrum cephalosporin 62 Alemtuzumab 62 Kit CD# positive 62 p# mitogen activated 62 ALN PCS 62 virus HCV infection 62 FGFR 62 administered subcutaneously 62 Litx 62 5 HT4 62 selective phosphodiesterase 62 melanocortin receptor agonists 62 valent conjugate vaccine 62 beta lactamase inhibitor 62 dacetuzumab 62 enkephalin 62 PSMA antibody 62 sorafenib Nexavar 62 alpha TNF 62 octreotide acetate 62 XmAb ® 62 PEG Interferon lambda 62 receptor agonists 62 active moiety 62 binds selectively 62 HER2 receptor 62 BRAF kinase 62 vaccine GRNVAC1 62 drug conjugate ADC 62 HuMax TAC 62 Pemetrexed 62 ocular formulation 62 Soliris eculizumab 62 FVIIa 62 anti CD3 antibody 62 anti fibrotic 62 serine protease 62 VQD 62 Vidaza azacitidine 62 small molecule thrombopoietin 62 Anticalins ® 62 KB# [004] 62 RNA antagonist 62 anticancer therapies 62 Exherin TM 62 topoisomerase II inhibitor 62 TBC# 62 Hycamtin 62 cleavable linker 62 daptomycin 62 SIRT2 62 Vorinostat 62 BCR ABL 62 siRNA therapeutics 62 recombinant interferon 62 BiTE ® 62 5 HT3 antagonist 62 IMGN# 62 T#I mutant 62 RELOVAIR ™ 62 Laquinimod 62 N acetylgalactosamine 6 61 specific lectin receptors 61 ADI PEG 61 Streptococcus pyogenes 61 TRAIL receptor 61 Gefitinib 61 tubulin inhibitor 61 multiple myeloma MM 61 Parkinson disease levodopa induced 61 Neulasta R 61 direct thrombin inhibitor 61 selectively inhibiting 61 leukemia CLL 61 aurora kinase 61 etanercept Enbrel 61 Homspera TM 61 Milatuzumab 61 IFN alpha 61 insulin sensitizer 61 acid phosphatase PAP 61 GPR# agonist 61 dextromethorphan quinidine 61 Atrasentan 61 prostaglandin D2 61 Ixempra 61 colony stimulating factor 61 auristatin 61 Eg5 61 Etoposide 61 investigational therapies 61 S#P# 61 TRO# 61 MOR# 61 Clofarabine 61 generation purine nucleoside 61 class mGluR5 inhibitor 61 tigecycline 61 ARC# [001] 61 DAVANAT 61 Lubiprostone 61 ErbB2 positive 61 BENLYSTA ® 61 OncoVex 61 retinoic acid receptor 61 Elagolix 61 Silodosin 61 generation Hsp# inhibitor 61 hematological cancers 61 POTELLIGENT ® 61 beta lactam 61 selectively inhibited 61 Marqibo TM 61 Epidermal Growth Factor 61 rHuPH# recombinant human 61 TRAIL receptors 61 NVA# 61 Crofelemer